Skip to Main Content

Author Details

Teresa Aydillo
Icahn School of Medicine at Mount Sinai
2011
37
23
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38054302Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines.Emerg Microbes Infect2024
37313413Group 1 and group 2 hemagglutinin stalk antibody response according to age.Front Immunol2023
35062328Obesity and Metabolic Dysregulation in Children Provide Protective Influenza Vaccine Responses.Viruses2022
35776647Protocol to isolate and assess spike protein cleavage in SARS-CoV-2 variants obtained from clinical COVID-19 samples.STAR Protoc2022
36496417Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.NPJ Vaccines2022
36112363Autoantibodies against type I IFNs in patients with critical influenza pneumonia.J Exp Med2022
36219456Immunodominance hierarchy after seasonal influenza vaccination.Emerg Microbes Infect2022
35247306Limited extent and consequences of pancreatic SARS-CoV-2 infection.Cell Rep2022
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
33288923A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial.Nat Med2021
33676971Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms.Gastroenterology2021
33836156TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.Cell2021
33961839Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.Hum Pathol2021
34145263Immunological imprinting of the antibody response in COVID-19 patients.Nat Commun2021
32511441A serological assay to detect SARS-CoV-2 seroconversion in humans.medRxiv2020
33299999Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.bioRxiv2020
33182279Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies.Vaccines (Basel)2020
33097660SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.Proc Natl Acad Sci U S A2020
33294855Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients.Cell Rep Med2020
33123119Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients.Front Immunol2020
33259154Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer.N Engl J Med2020
32398876A serological assay to detect SARS-CoV-2 seroconversion in humans.Nat Med2020
30787439MHC class II proteins mediate cross-species entry of bat influenza viruses.Nature2019
31921042Functional Characterization and Direct Comparison of Influenza A, B, C, and D NS1 Proteins <i>in vitro</i> and <i>in vivo</i>.Front Microbiol2019
29321309Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses.J Virol2018
29635437A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.Clin Infect Dis2018
28362949Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.Clin Infect Dis2017
27791106Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.Proc Natl Acad Sci U S A2016
26232537Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.Clin Microbiol Infect2015
26246567Novel Bat Influenza Virus NS1 Proteins Bind Double-Stranded RNA and Antagonize Host Innate Immunity.J Virol2015
25168918Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.Trials2014
23692602Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.Pediatr Transplant2013
21792558Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection.Eur J Clin Microbiol Infect Dis2012
23078072Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease.Clin Microbiol Infect2012
22820034Unexpected severity of cases of influenza B infection in patients that required hospitalization during the first postpandemic wave.J Infect2012
22377789Deficient long-term response to pandemic vaccine results in an insufficient antibody response to seasonal influenza vaccination in solid organ transplant recipients.Transplantation2012
21831151Therapy with m-TOR inhibitors decreases the response to the pandemic influenza A H1N1 vaccine in solid organ transplant recipients.Am J Transplant2011
  • 1 - 37 of 37

Recommended Authors

Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 2017
Number of shared co-authors 7
Yale School of Medicine
Career Start Year 2014
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 1
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 3
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 6
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 0
FluGen Inc.
Career Start Year 2007
Number of shared co-authors 0
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Career Start Year 2007
Number of shared co-authors 1
University of California san francisco
Career Start Year 2006
Number of shared co-authors 7
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 5
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 12
Vanderbilt University Medical Center
Career Start Year 2005
Number of shared co-authors 1
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 4
University of Iowa
Career Start Year 2002
Number of shared co-authors 23
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 9
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 7
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1995
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 31
US Centers for Disease Control and Prevention
Career Start Year 1993
Number of shared co-authors 0
Center for Pathogen Research, University of Maryland School of Medicine
Career Start Year 1993
Number of shared co-authors 16
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 7
Centers for Disease Control and Prevention.
Career Start Year 1989
Number of shared co-authors 17
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 2
University of North Carolina
Career Start Year 1981
Number of shared co-authors 7
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 11
Vanderbilt University Medical Center
Career Start Year 1975
Number of shared co-authors 4
University of Michigan School of Public Health ann arbor
Career Start Year 1959
Number of shared co-authors 2

Collaborators

Icahn School of Medicine at Mount Sinai
Co-authored papers 25
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 5
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Hospital Universitario Ramon y Cajal
Co-authored papers 5
Institute of Virology, Medical Center - University of Freiburg
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
The Scripps Research Institute
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
College of Veterinary Medicine, Kansas State University
Co-authored papers 3
University of South Florida
Co-authored papers 3
Michigan State University College of Human Medicine
Co-authored papers 3
Albert Einstein College of Medicine
Co-authored papers 3
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
College of Veterinary Medicine, Kansas State University
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers 2
University of Cincinnati College of Medicine
Co-authored papers 2
Co-authored papers 2
Department of Computer Science and Informatics Institute, University of Missouri
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
U.C. San Diego School of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 2